Literature DB >> 22064389

Preemptive genotyping trialed to prevent adverse drug reactions.

Elie Dolgin.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 22064389     DOI: 10.1038/nm1111-1323

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  Primary care physicians' knowledge of and experience with pharmacogenetic testing.

Authors:  S B Haga; W Burke; G S Ginsburg; R Mills; R Agans
Journal:  Clin Genet       Date:  2012-07-03       Impact factor: 4.438

Review 2.  Advances in the Pharmacogenomics of Adverse Drug Reactions.

Authors:  Susannah L Collins; Daniel F Carr; Munir Pirmohamed
Journal:  Drug Saf       Date:  2016-01       Impact factor: 5.606

3.  Reducing severe cutaneous adverse and type B adverse drug reactions using pre-stored human leukocyte antigen genotypes.

Authors:  Kye Hwa Lee; Dong Yoon Kang; Hyun Hwa Kim; Yi Jun Kim; Hyo Jung Kim; Ju Han Kim; Eun Young Song; James Yun; Hye-Ryun Kang
Journal:  Clin Transl Allergy       Date:  2022-01-14       Impact factor: 5.871

Review 4.  CYP2B6 Functional Variability in Drug Metabolism and Exposure Across Populations-Implication for Drug Safety, Dosing, and Individualized Therapy.

Authors:  Immaculate M Langmia; Katja S Just; Sabrina Yamoune; Jürgen Brockmöller; Collen Masimirembwa; Julia C Stingl
Journal:  Front Genet       Date:  2021-07-12       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.